240 related articles for article (PubMed ID: 16213689)
1. Serotonin and dopamine transporter imaging in patients with obsessive-compulsive disorder.
Hesse S; Müller U; Lincke T; Barthel H; Villmann T; Angermeyer MC; Sabri O; Stengler-Wenzke K
Psychiatry Res; 2005 Oct; 140(1):63-72. PubMed ID: 16213689
[TBL] [Abstract][Full Text] [Related]
2. [123I]-beta-CIT SPECT imaging shows reduced thalamus-hypothalamus serotonin transporter availability in 24 drug-free obsessive-compulsive checkers.
Zitterl W; Aigner M; Stompe T; Zitterl-Eglseer K; Gutierrez-Lobos K; Schmidl-Mohl B; Wenzel T; Demal U; Zettinig G; Hornik K; Thau K
Neuropsychopharmacology; 2007 Aug; 32(8):1661-8. PubMed ID: 17192774
[TBL] [Abstract][Full Text] [Related]
3. Changes in thalamus-hypothalamus serotonin transporter availability during clomipramine administration in patients with obsessive-compulsive disorder.
Zitterl W; Aigner M; Stompe T; Zitterl-Eglseer K; Gutierrez-Lobos K; Wenzel T; Zettinig G; Hornik K; Pirker W; Thau K
Neuropsychopharmacology; 2008 Dec; 33(13):3126-34. PubMed ID: 18354388
[TBL] [Abstract][Full Text] [Related]
4. Reduced serotonin transporter-availability in obsessive-compulsive disorder (OCD).
Stengler-Wenzke K; Müller U; Angermeyer MC; Sabri O; Hesse S
Eur Arch Psychiatry Clin Neurosci; 2004 Aug; 254(4):252-5. PubMed ID: 15309396
[TBL] [Abstract][Full Text] [Related]
5. Serotonin transporter imaging with [123I]beta-CIT SPECT before and after one year of citalopram treatment of obsessive-compulsive disorder.
Stengler-Wenzke K; Müller U; Barthel H; Angermeyer MC; Sabri O; Hesse S
Neuropsychobiology; 2006; 53(1):40-5. PubMed ID: 16397403
[TBL] [Abstract][Full Text] [Related]
6. Serotonin 2A receptor, serotonin transporter and dopamine transporter alterations in dogs with compulsive behaviour as a promising model for human obsessive-compulsive disorder.
Vermeire S; Audenaert K; De Meester R; Vandermeulen E; Waelbers T; De Spiegeleer B; Eersels J; Dobbeleir A; Peremans K
Psychiatry Res; 2012 Jan; 201(1):78-87. PubMed ID: 22285716
[TBL] [Abstract][Full Text] [Related]
7. The serotonin transporter availability in untreated early-onset and late-onset patients with obsessive-compulsive disorder.
Hesse S; Stengler K; Regenthal R; Patt M; Becker GA; Franke A; Knüpfer H; Meyer PM; Luthardt J; Jahn I; Lobsien D; Heinke W; Brust P; Hegerl U; Sabri O
Int J Neuropsychopharmacol; 2011 Jun; 14(5):606-17. PubMed ID: 21232166
[TBL] [Abstract][Full Text] [Related]
8. Serotonin and dopamine transporter availabilities correlate with the loudness dependence of auditory evoked potentials in patients with obsessive-compulsive disorder.
Pogarell O; Tatsch K; Juckel G; Hamann C; Mulert C; Pöpperl G; Folkerts M; Choukèr M; Riedel M; Zaudig M; Möller HJ; Hegerl U
Neuropsychopharmacology; 2004 Oct; 29(10):1910-7. PubMed ID: 15292904
[TBL] [Abstract][Full Text] [Related]
9. Dopamine transporter density of basal ganglia assessed with [123I]IPT SPET in obsessive-compulsive disorder.
Kim CH; Koo MS; Cheon KA; Ryu YH; Lee JD; Lee HS
Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):1637-43. PubMed ID: 14513291
[TBL] [Abstract][Full Text] [Related]
10. Enhanced dopamine transporter density in psychotropic-naive patients with obsessive-compulsive disorder shown by [123I]{beta}-CIT SPECT.
van der Wee NJ; Stevens H; Hardeman JA; Mandl RC; Denys DA; van Megen HJ; Kahn RS; Westenberg HM
Am J Psychiatry; 2004 Dec; 161(12):2201-6. PubMed ID: 15569890
[TBL] [Abstract][Full Text] [Related]
11. Elevated brain serotonin transporter availability in patients with obsessive-compulsive disorder.
Pogarell O; Hamann C; Pöpperl G; Juckel G; Choukèr M; Zaudig M; Riedel M; Möller HJ; Hegerl U; Tatsch K
Biol Psychiatry; 2003 Dec; 54(12):1406-13. PubMed ID: 14675805
[TBL] [Abstract][Full Text] [Related]
12. Reduced midbrain-pons serotonin transporter binding in patients with obsessive-compulsive disorder.
Hasselbalch SG; Hansen ES; Jakobsen TB; Pinborg LH; Lønborg JH; Bolwig TG
Acta Psychiatr Scand; 2007 May; 115(5):388-94. PubMed ID: 17430417
[TBL] [Abstract][Full Text] [Related]
13. Test-retest reproducibility of extrastriatal binding with
Matsuoka K; Yasuno F; Shinkai T; Miyasaka T; Takahashi M; Kiuchi K; Kosaka J; Inoue M; Kichikawa K; Hasegawa M; Kishimoto T
Psychiatry Res Neuroimaging; 2016 Dec; 258():10-15. PubMed ID: 27814458
[No Abstract] [Full Text] [Related]
14. Serotonin transporter binding in Tourette Syndrome.
Müller-Vahl KR; Meyer GJ; Knapp WH; Emrich HM; Gielow P; Brücke T; Berding G
Neurosci Lett; 2005 Sep; 385(2):120-5. PubMed ID: 15936877
[TBL] [Abstract][Full Text] [Related]
15. Midbrain serotonin and striatum dopamine transporter binding in double depression: a one-year follow-up study.
Lehto SM; Tolmunen T; Kuikka J; Valkonen-Korhonen M; Joensuu M; Saarinen PI; Vanninen R; Ahola P; Tiihonen J; Lehtonen J
Neurosci Lett; 2008 Aug; 441(3):291-5. PubMed ID: 18588943
[TBL] [Abstract][Full Text] [Related]
16. Dopamine transporter imaging in adult patients with attention-deficit/hyperactivity disorder.
Hesse S; Ballaschke O; Barthel H; Sabri O
Psychiatry Res; 2009 Feb; 171(2):120-8. PubMed ID: 19176281
[TBL] [Abstract][Full Text] [Related]
17. Dopamine transporter density in the basal ganglia in obsessive-compulsive disorder, measured with [123I]IPT SPECT before and after treatment with serotonin reuptake inhibitors.
Kim CH; Cheon KA; Koo MS; Ryu YH; Lee JD; Chang JW; Lee HS
Neuropsychobiology; 2007; 55(3-4):156-62. PubMed ID: 17657168
[TBL] [Abstract][Full Text] [Related]
18. Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers.
Staley JK; Krishnan-Sarin S; Zoghbi S; Tamagnan G; Fujita M; Seibyl JP; Maciejewski PK; O'Malley S; Innis RB
Synapse; 2001 Sep; 41(4):275-84. PubMed ID: 11494398
[TBL] [Abstract][Full Text] [Related]
19. The response to prolonged fasting in hypothalamic serotonin transporter availability is blunted in obesity.
van Galen KA; Booij J; Schrantee A; Adriaanse SM; Unmehopa UA; Fliers E; Schwartz GJ; DiLeone RJ; Ter Horst KW; la Fleur SE; Serlie MJ
Metabolism; 2021 Oct; 123():154839. PubMed ID: 34331964
[TBL] [Abstract][Full Text] [Related]
20. Diencephalic serotonin transporter availability predicts both transporter occupancy and treatment response to sertraline in obsessive-compulsive checkers.
Zitterl W; Stompe T; Aigner M; Zitterl-Eglseer K; Ritter K; Zettinig G; Hornik K; Asenbaum S; Pirker W; Thau K
Biol Psychiatry; 2009 Dec; 66(12):1115-22. PubMed ID: 19717141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
